1
|
Deriaz S, Serratrice C, Lidove O, Noël E, Masseau A, Lorcerie B, Jaussaud R, Marie I, Lavigne C, Cabane J, Kaminsky P, Chérin P, Maillot F. [Diagnostic journey of type 1 Gaucher Disease patients: A survey including internists and hematologists]. Rev Med Interne 2019; 40:778-784. [PMID: 31500934 DOI: 10.1016/j.revmed.2019.07.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Revised: 06/22/2019] [Accepted: 07/15/2019] [Indexed: 10/26/2022]
Abstract
INTRODUCTION Gaucher disease (GD) is a rare genetic lysosomal storage disorder caused by a beta-glucocerebrosidase deficiency and responsible for a lysosomal storage disorder. GD is characterized by haematological, visceral and bone involvements. The aim of this study was to describe the diagnostic journey of type 1 GD patients as well as the role of the internist. METHODS A retrospective multicentric study involving type 1 GD patients has been conducted in 16 centers, between 2009 and 2011. RESULTS Fifty-five type 1 GD patients were included, under the care of an internist or an haematologist. They were originally hospitalized in 8 different specialized units. Diagnosis was established by bone-marrow aspiration in 22 patients (40%), by enzymatic assay of glucocerebrosidase activity in 15 patients (27%), and by bone-marrow biopsy in 9 patients (16%). The use of enzymatic assay became more frequent after 1990. The delay between first hospitalization due to GD symptoms and definitive diagnosis was less than one year for 38 patients. Patients with suspected GD were mainly referred to an internist physician. CONCLUSION GD seems to be better recognized and quickly diagnosed since 1990 in spite of the multiplicity of journeys. The role of the internist seems important.
Collapse
Affiliation(s)
- S Deriaz
- CHRU, université de Tours, service de médecine interne, Tours, France
| | - C Serratrice
- Service de médecine interne, hôpital Saint-Joseph, Marseille, France; Département de médecine interne et réhabilitation, hôpital universitaire de Genève, Suisse
| | - O Lidove
- Service de médecine interne, hôpital de la Croix Saint-Simon, Paris, France
| | - E Noël
- Service de médecine interne, CHRU de Strasbourg, Strasbourg, France
| | - A Masseau
- Service de médecine interne, CHRU de Nantes, Nantes, France
| | - B Lorcerie
- Service de médecine interne, CHRU de Dijon, Dijon, France
| | - R Jaussaud
- Service de médecine interne, CHRU de Reims, Reims, France
| | - I Marie
- Service de médecine interne, CHRU de Rouen, Rouen, France
| | - C Lavigne
- Service de médecine interne, CHRU d'Angers, Angers, France
| | - J Cabane
- Service de médecine interne, hôpital Saint-Antoine, Paris, France
| | - P Kaminsky
- Service de médecine interne, CHRU de Nancy, Nancy, France
| | - P Chérin
- Service de médecine interne, hôpital de la Pitié-Salpétrière, Paris, France
| | - F Maillot
- CHRU, université de Tours, service de médecine interne, Tours, France.
| | | |
Collapse
|
2
|
Lorcerie B, Audia S, Samson M, Millière A, Falvo N, Leguy-Seguin V, Berthier S, Bonnotte B. Démarche diagnostique devant une hyperferritinémie. Rev Med Interne 2015; 36:522-9. [DOI: 10.1016/j.revmed.2014.12.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2014] [Revised: 12/18/2014] [Accepted: 12/22/2014] [Indexed: 01/30/2023]
|
3
|
Zuily S, de Laat B, Mohamed S, Kelchtermans H, Shums Z, Albesa R, Norman GL, Lamboux-Matthieu C, Rat AC, Ninet J, Magy-Bertrand N, Pasquali JL, Lambert M, Lorcerie B, Kaminsky P, Guillemin F, Regnault V, Wahl D. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study. Rheumatology (Oxford) 2015; 54:2071-5. [PMID: 26163690 DOI: 10.1093/rheumatology/kev238] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2015] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE To investigate the validity of the global APS score (GAPSS) to predict thrombosis in patients with autoimmune diseases. METHODS This prospective cohort study included consecutive patients with aPL or SLE. aPL, aPS-PT and GAPSS were determined. A Cox proportional hazards model assessed the validity of GAPSS and identified other potential independent predictors of thrombosis. RESULTS One hundred and thirty-seven patients [43.5 (s.d. 15.4) years old; 107 women] were followed up for a mean duration of 43.1 (s.d. 20.7) months. Mean GAPSS was significantly higher in patients who experienced a thrombotic event compared with those without [10.88 (s.d. 5.06) vs 8.15 (s.d. 5.31), respectively, P = 0.038]. In univariate analysis, age [hazard ratio (HR) = 1.04 (95% CI 1.01, 1.08)] and GAPSS above 16 [HR = 6.86 (95% CI 1.90, 24.77)] were each significantly associated with thrombosis during follow-up, while history of arterial thrombosis [HR = 2.61 (95% CI 0.87, 7.82)] failed to reach significance. Among aPL assays, IgG aPS/PT--a component of the GAPSS--was significantly associated with thrombosis [HR = 2.95 (95% CI 1.02, 8.51)]. In multivariate analysis, GAPSS above 16 remained the only significant predictor of thrombosis [HR = 6.17 (95% CI 1.70, 22.40)]. CONCLUSION This first external validation study confirmed that GAPSS can predict thrombosis in patients with aPL and associated autoimmune diseases.
Collapse
Affiliation(s)
- Stéphane Zuily
- CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division, Inserm, UMRS 1116, Nancy School of Medicine, Université de Lorraine, Nancy, France,
| | - Bas de Laat
- Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Clinical Chemistry and Haematology, University Medical Centre Utrecht, Synapse BV, Maastricht, Department of Plasma Proteins/Blood coagulation, Sanquin Research, Amsterdam, The Netherlands
| | - Shirine Mohamed
- Nancy School of Medicine, Université de Lorraine, Nancy, France, CHU de Nancy, Orphan Disease Unit, Nancy, France
| | - Hilde Kelchtermans
- Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht
| | - Zakera Shums
- Research and Development, Inova Diagnostics, San Diego, CA, USA
| | - Roger Albesa
- Research and Development, Inova Diagnostics, San Diego, CA, USA
| | - Gary L Norman
- Research and Development, Inova Diagnostics, San Diego, CA, USA
| | - Claire Lamboux-Matthieu
- CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division
| | - Anne-Christine Rat
- Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Inserm, CIC-EC 1433, CHU de Nancy, Clinical Epidemiology and Evaluation Department, CHU de Nancy, Rheumatology Department, Nancy
| | | | | | - Jean-Louis Pasquali
- CHU de Strasbourg, Internal Medicine and Clinical Immunology Department, Strasbourg, F-67000
| | - Marc Lambert
- CHRU de Lille, Department of Internal Medicine, Lille
| | - Bernard Lorcerie
- CHU de Dijon, Internal Medicine and Clinical Immunology Department, Dijon and
| | - Pierre Kaminsky
- Nancy School of Medicine, Université de Lorraine, Nancy, France, CHU de Nancy, Orphan Disease Unit, Nancy, France
| | - Francis Guillemin
- Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Inserm, CIC-EC 1433, CHU de Nancy, Clinical Epidemiology and Evaluation Department
| | | | - Denis Wahl
- CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division, Inserm, UMRS 1116, Nancy School of Medicine, Université de Lorraine, Nancy, France
| | | |
Collapse
|
4
|
Bouiller K, Samson M, Eicher JC, Audia S, Berthier S, Leguy V, Humbert O, Martin L, Lorgis L, Cottin Y, Bonnotte B, Lorcerie B. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis. Intern Med J 2015; 44:928-31. [PMID: 25201426 DOI: 10.1111/imj.12525] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2014] [Accepted: 03/30/2014] [Indexed: 01/06/2023]
Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare form of systemic vasculitis in which cardiac involvement is frequent and severe, and accounts for half of EGPA-related deaths. ANCA-positive EGPA differs from ANCA-negative EGPA in that the former is significantly associated with renal involvement, peripheral neuropathy and biopsy proven vasculitis, whereas the latter is associated with cardiac involvement. Herein, we report a case of EGPA with myocarditis in a woman, who was successfully treated with steroids and cyclophosphamide. This report highlights the importance of diagnosing cardiac involvement in EGPA early, especially in ANCA-negative patients.
Collapse
Affiliation(s)
- K Bouiller
- Department of Internal Medicine and Clinical Immunology, University Hospital of Dijon, Dijon, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Zuily S, Rat AC, Regnault V, Kaminsky P, Mismetti P, Ninet J, Baillet N, Magy-Bertrand N, Pasquali JL, Lambert M, Pasquier E, Lorcerie B, Lecompte T, Guillemin F, Wahl D. Impairment of quality of life in patients with antiphospholipid syndrome. Lupus 2015; 24:1161-8. [PMID: 25862730 DOI: 10.1177/0961203315580871] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2014] [Accepted: 03/17/2015] [Indexed: 11/15/2022]
Abstract
OBJECTIVES Health-related quality of life (HRQoL) has not been fully explored in antiphospholipid syndrome (APS); therefore, we compared HRQoL between APS patients and the general population and assessed the impact of thromboembolic history. METHODS HRQoL was measured in a multicentre cohort study by the Medical Outcomes Study Short-Form 36 (MOS-SF-36) questionnaire. HRQoL scores were compared to the French general population norms. Factors significantly associated with an impaired HRQoL were identified. RESULTS A total of 115 patients with aPL and/or systemic lupus erythematosus (SLE) were included (mean age 42.7 ± 14.1 years old, 86 women). In 53 patients APS was diagnosed. Compared to general population norms, patients with APS had an impaired HRQoL. SLE-associated APS patients had the worst HRQoL scores (physical component summary (PCS)=40.8 ± 10.6; mental component summary (MCS)=40.6 ± 16.5) in comparison with SLE or aPL patients without thromboembolic history. In APS patients, history of arterial thrombosis significantly impaired HRQoL (PCS score: 42.2 ± 9.4 vs 49.2 ± 8.5; MCS score: 33.9 ± 13.7 vs 44.6 ± 10.3). CONCLUSION Compared to the general population, APS patients experienced a lower HRQoL. In these patients, a history of arterial thrombosis significantly impaired HRQoL. Therefore, measurements of HRQoL should be included in APS patient management to assess the burden of the disease from a patient's perspective and to provide patients with the support they need.
Collapse
Affiliation(s)
- S Zuily
- CHU de Nancy, Vascular Medicine Division and Regional Competence Centre for Systemic and Autoimmune Diseases, Nancy, France Inserm, UMR_S 1116, Nancy, France Université de Lorraine, Nancy, France
| | - A-C Rat
- Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France Inserm, CIC-EC CIE6, Nancy, France CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, France CHU de Nancy, Rheumatology Department, Nancy, France
| | - V Regnault
- Inserm, UMR_S 1116, Nancy, France Université de Lorraine, Nancy, France CHU de Nancy, Contrat d'interface, Nancy, France
| | - P Kaminsky
- Université de Lorraine, Nancy, France CHU de Nancy, Orphan Disease Unit, Nancy, France
| | - P Mismetti
- CHU de Saint Etienne, Clinical Pharmacology Unit and EA 3065, Saint-Etienne, France
| | - J Ninet
- CHU de Lyon, Department of Internal Medicine, Lyon, France
| | - N Baillet
- Colmar Hospital, Department of Internal Medicine, Colmar, France
| | - N Magy-Bertrand
- CHU de Besançon, Internal Medicine and Clinical Immunology Department, Besançon, France
| | - J-L Pasquali
- CHU de Strasbourg, Internal Medicine and Clinical Immunology Department, Strasbourg, France
| | - M Lambert
- CHRU de Lille, Department of Internal Medicine, Lille, France
| | - E Pasquier
- CHU de Brest, Department of Internal Medicine and Chest Diseases and EA 3878, Brest, France
| | - B Lorcerie
- CHU de Dijon, Internal Medicine and Clinical Immunology Department, Dijon, France
| | - T Lecompte
- Université de Lorraine, Nancy, France University Hospitals of Geneva, Division of Haematology, Geneva, Switzerland (T.L. current address)
| | - F Guillemin
- Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, France
| | - D Wahl
- CHU de Nancy, Vascular Medicine Division and Regional Competence Centre for Systemic and Autoimmune Diseases, Nancy, France Inserm, UMR_S 1116, Nancy, France Université de Lorraine, Nancy, France
| | | |
Collapse
|
6
|
Samson M, Jacquin A, Audia S, Daubail B, Devilliers H, Petrella T, Martin L, Durier J, Besancenot JF, Lorcerie B, Giroud M, Bonnotte B, Béjot Y. Stroke associated with giant cell arteritis: a population-based study. J Neurol Neurosurg Psychiatry 2015; 86:216-21. [PMID: 24780954 DOI: 10.1136/jnnp-2014-307614] [Citation(s) in RCA: 84] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
BACKGROUND Giant cell arteritis (GCA) is the most common vasculitis in people ≥50 years and can be associated with stroke. We aimed to evaluate the epidemiology and characteristics of stroke in patients with GCA. METHODS All patients with a biopsy-proven diagnosis of GCA were identified among residents of the city of Dijon, France (152 000 inhabitants), between 2001 and 2012 using a prospective database. Among these, patients who suffered from stroke were retrieved by crossing data from the population-based Dijon Stroke Registry. Demographics and clinical features were recorded. We considered that the stroke was GCA-related if the stroke revealed GCA or occurred between the onset of symptoms and 4 weeks after the start of treatment. RESULTS Among the 57 biopsy-proven patients with GCA (incidence rate 10.9/100 000/year in individuals ≥50 years), 4 (7.0%) experienced a GCA-related stroke. Three were men and all had ≥2 vascular risk factors and were ≥80 years. The stroke was vertebrobasilar for 3/4 patients and undetermined for the remaining one. The incidence rate of GCA-related stroke in patients ≥50 years was 0.76/100 000/year (95% CI 0 to 2.47), 1.36/100 000/year in men (95% CI 0 to 3.63) and 0.33/100 000/year (95% CI 0 to 1.45) in women. CONCLUSIONS This population-based study demonstrated that GCA-related stroke essentially affects the vertebrobasilar territory and mainly occurs in old men with associated vascular risk factors. Although rare, GCA symptoms must be searched for in elderly patients with stroke, and optimal vascular prevention must be conducted carefully in patients with GCA with a high vascular risk before initiating GCA treatment.
Collapse
Affiliation(s)
- Maxime Samson
- Service de Médecine Interne et Immunologie Clinique, CHU de Dijon, Dijon, France INSERM, UMR1098, Besançon Cedex, France Faculté de Médecine, Université de Bourgogne, Dijon, France
| | - Agnès Jacquin
- Dijon Stroke Registry, EA4184, Department of Neurology, University Hospital and Medical School of Dijon, University of Burgundy, France
| | - Sylvain Audia
- Service de Médecine Interne et Immunologie Clinique, CHU de Dijon, Dijon, France INSERM, UMR1098, Besançon Cedex, France Faculté de Médecine, Université de Bourgogne, Dijon, France
| | - Benoit Daubail
- Dijon Stroke Registry, EA4184, Department of Neurology, University Hospital and Medical School of Dijon, University of Burgundy, France
| | - Hervé Devilliers
- Service de Médecine Interne et maladies systémiques, CHU de Dijon, Dijon, France
| | - Tony Petrella
- Service d'anatomie et cytologie pathologiques, CHU de Dijon, Dijon, France
| | - Laurent Martin
- Service d'anatomie et cytologie pathologiques, CHU de Dijon, Dijon, France
| | - Jérôme Durier
- Dijon Stroke Registry, EA4184, Department of Neurology, University Hospital and Medical School of Dijon, University of Burgundy, France
| | | | - Bernard Lorcerie
- Service de Médecine Interne et Immunologie Clinique, CHU de Dijon, Dijon, France
| | - Maurice Giroud
- Dijon Stroke Registry, EA4184, Department of Neurology, University Hospital and Medical School of Dijon, University of Burgundy, France
| | - Bernard Bonnotte
- Service de Médecine Interne et Immunologie Clinique, CHU de Dijon, Dijon, France INSERM, UMR1098, Besançon Cedex, France Faculté de Médecine, Université de Bourgogne, Dijon, France
| | - Yannick Béjot
- Dijon Stroke Registry, EA4184, Department of Neurology, University Hospital and Medical School of Dijon, University of Burgundy, France
| |
Collapse
|
7
|
Blot M, Boyer P, Samson M, Audia S, Devilliers H, Leguy V, Berthier S, Besancenot JF, Lorcerie B, Lakomy D, Bonnotte B. Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia. Eur J Intern Med 2014; 25:837-42. [PMID: 25307285 DOI: 10.1016/j.ejim.2014.09.009] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/23/2014] [Revised: 07/21/2014] [Accepted: 09/15/2014] [Indexed: 01/08/2023]
Abstract
BACKGROUND Although secondary hypogammaglobulinemia is more frequent than primary hypogammaglobulinemia, its etiology and management are poorly described, particularly for mild hypogammaglobulinemia. METHODS This retrospective observational study included all adult patients with a gammaglobulin level <6.4g/L on serum electrophoresis identified at Dijon teaching hospital between April and September 2012. Clinico-biological features, etiologies and infectious complications were collected at inclusion and compared between group 1 (gammaglobulin <5g/L, severe hypogammaglobulinemia), and group 2 (gammaglobulin <6.4 and ≥5g/L, mild hypogammaglobulinemia). RESULTS Among the 4011 serum electrophoreses, 570 samples from 389 patients had gammaglobulin levels below 6.4g/L: 156 (40%) in group 1 and 233 (60%) in group 2. Mean age±SD was 67 (15) years, and sex ratio was 1.04 (M/F) with no difference between the two groups. An etiology was identified in 79% and 58% of patients in groups 1 and 2, respectively (p<0.0001). The main etiologies were similar in both groups and included malignant hemopathy treated with cytostatic agents (n=129, 33%), smoldering or newly-diagnosed hemopathy without treatment (n=49, 13%) and immunosuppressive treatment (n=91, 23%). The incidence of hypogammaglobulinemia-related infections was 22/100/year, with no significant difference between the two groups (p=0.17). Vaccination coverage against pneumococcus was 33%, and higher in group 1 (46% vs. 24%; p<0.0001). When no cause was known at inclusion, an etiology was discovered in 22/130 patients (17%), 11 in each group. CONCLUSIONS Though mild hypogammaglobulinemia does not meet the classical criteria for hypogammaglobulinemia (<5g/L), the etiology and infectious risk are similar. It therefore requires investigation and vaccination.
Collapse
Affiliation(s)
- Mathieu Blot
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21079 Dijon, France
| | - Pierre Boyer
- Laboratory of Immunology, Dijon University Hospital, 21079 Dijon, France
| | - Maxime Samson
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21079 Dijon, France; Faculty of Medicine, University of Burgundy, Dijon, France; INSERM, UMR1098, University of Franche-Comté, 25030 Besançon, France
| | - Sylvain Audia
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21079 Dijon, France; Faculty of Medicine, University of Burgundy, Dijon, France; INSERM, UMR1098, University of Franche-Comté, 25030 Besançon, France
| | - Hervé Devilliers
- Faculty of Medicine, University of Burgundy, Dijon, France; Department of Internal Medicine and Systemic Diseases, Dijon University Hospital, 21079 Dijon, France
| | - Vanessa Leguy
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21079 Dijon, France
| | - Sabine Berthier
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21079 Dijon, France
| | - Jean-François Besancenot
- Faculty of Medicine, University of Burgundy, Dijon, France; Department of Internal Medicine and Systemic Diseases, Dijon University Hospital, 21079 Dijon, France
| | - Bernard Lorcerie
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21079 Dijon, France; Faculty of Medicine, University of Burgundy, Dijon, France
| | - Daniela Lakomy
- Laboratory of Immunology, Dijon University Hospital, 21079 Dijon, France; Faculty of Medicine, University of Burgundy, Dijon, France
| | - Bernard Bonnotte
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, 21079 Dijon, France; Faculty of Medicine, University of Burgundy, Dijon, France; INSERM, UMR1098, University of Franche-Comté, 25030 Besançon, France.
| |
Collapse
|
8
|
Eicher JC, Berthier S, Aho LS, Lorcerie B, Bonnotte B, Laurent G. Measurement of interatrial dyssynchrony using tissue Doppler imaging predicts functional capacity and cardiac involvement in systemic sclerosis. Clin Exp Rheumatol 2014; 32:S-171-6. [PMID: 25372800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2014] [Accepted: 07/07/2014] [Indexed: 06/04/2023]
Abstract
OBJECTIVES We aimed to assess the prevalence of interatrial electromechanical dyssynchrony in systemic sclerosis (SSc) patients, and to study the correlation between interatrial delay and standard follow-up parameters. METHODS Forty consecutive patients with SSc were studied. Classical echocardiographic measurements were obtained, including indices of left ventricular (LV) systolic and diastolic function, right ventricular function, and pulmonary artery pressure (PAP). Left atrial (LA) function was studied using volume measurements. The interatrial mechanical (IAMD) delay was obtained by measuring the time delay between the peak atrial velocities at the lateral tricuspid and mitral annuli using tissue Doppler imaging. A cut-off value of 35 ms was chosen to define the presence of a significant interatrial delay. The IAMD was compared to NYHA class, six-minute walking test (6MWT), NT proBNP levels, and the carbon monoxide diffusion capacity over alveolar volume ratio (DLCO/VA), as well as to classical echocardiographic parameters. RESULTS Forty percent of patients were found to have significant interatrial dyssynchrony with an IAMD of 35 ms or more. Patients with interatrial dyssynchrony were more symptomatic, had a shorter 6MWT, higher NT proBNP levels, and a lower DLCO/VA compared with those without dyssynchrony. Regarding conventional echocardiographic parameters, increased IAMD was associated with more pronounced LV diastolic dysfunction, LA enlargement and dysfunction, altered RV function, and higher PAP. CONCLUSIONS IAMD correlated with all of the standard follow-up parameters in SSc, and is probably a sensitive marker of LA involvement. This easy to measure parameter should be added to the routine echocardiographic assessment of these patients.
Collapse
Affiliation(s)
- J-C Eicher
- Department of Cardiology, Rhythmology and Heart Failure Unit, Hôpital Bocage Central, CHU de Dijon, France.
| | | | | | | | | | | |
Collapse
|
9
|
Leguy-Seguin V, Samson M, Audia S, Berthier S, Mousson de Camaret B, Thauvin C, Bonnotte B, Lorcerie B. Une randonnée en montagne comme test diagnostique ! Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Audia S, Rossato M, Samson M, Santegoets K, Berthier S, Leguy-Seguin V, Janikashvili N, Lorcerie B, Radstake T, Bonnotte B. Implication des lymphocytes T folliculaires auxiliaires spléniques au cours de la thrombopénie immunologique. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
11
|
Guilhem A, Simon AC, Duffau P, Carette MF, Bletry O, Harle JR, Kaminsky P, Lorcerie B, Lerolle N, Lavigne C, Dupuis-Girod S, Rivière S. Utilisation du bevacizumab au cours de la maladie de Rendu-Osler : étude rétrospective de 30 cas. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
12
|
Blot M, Boyer P, Samson M, Leguy-Seguin V, Audia S, Berthier S, Besancenot J, Lakomy D, Lorcerie B, Bonnotte B. Étude rétrospective des hypogammaglobulinémies secondaires de l’adulte pendant 6mois au CHU de Dijon : étiologies, conséquences infectieuses et pratiques vaccinales. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
Mouriès-Martin S, Bach B, Leguy-Seguin V, Berthier S, Bonnotte B, Samson M, Volot F, Demaistre E, Lorcerie B. Traitement par facteurs de coagulation dans l’hémophilie acquise : effets secondaires. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
Breuvart E, Berthier S, Hars B, Nicolas B, Leguy-Seguin V, Samson M, Milliere A, Bonnotte B, Lorcerie B. Étude de la conformité des prescriptions d’inhibiteurs de la pompe à protons aux recommandations HAS de 2009 : étude prospective sur 208 patients. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
15
|
Samson M, Audia S, Jacquin A, Leguy-Seguin V, Berthier S, Devilliers H, Martin L, Besancenot J, Lorcerie B, Giroud M, Bonnotte B, Béjot Y. Incidence et caractéristiques des accidents vasculaires cérébraux associés à l’artérite à cellules géantes. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
16
|
Blot M, Samson M, Leguy-Seguin V, Audia S, Lakomy D, Humbel RL, Eicher JC, Garnier F, Millière A, Berthier S, Bonnotte B, Lorcerie B. Élévation des IgA au cours d’une polyarthrite rhumatoïde : qui est le coupable ? Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
Bouiller K, Samson M, Eicher JC, Berthier S, Audia S, Milliere A, Lorgis L, Martin L, Cottin Y, Bonnotte B, Lorcerie B. Un diagnostic à ne pas rater devant une myocardite. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Samson M, Audia S, Fraszczak J, Trad M, Ornetti P, Lakomy D, Ciudad M, Leguy V, Berthier S, Vinit J, Manckoundia P, Maillefert JF, Besancenot JF, Aho-Glele S, Olsson NO, Lorcerie B, Guillevin L, Mouthon L, Saas P, Bateman A, Martin L, Janikashvili N, Larmonier N, Bonnotte B. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis. ACTA ACUST UNITED AC 2013; 64:3788-98. [PMID: 22833233 DOI: 10.1002/art.34647] [Citation(s) in RCA: 143] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
OBJECTIVE Giant cell arteritis (GCA) is the most frequently occurring vasculitis in elderly individuals, and its pathogenesis is not fully understood. The objective of this study was to decipher the role of the major CD4+ T cell subsets in GCA and its rheumatologic form, polymyalgia rheumatica (PMR). METHODS A prospective study of the phenotype and the function of major CD4+ T cell subsets (Th1, Th17, and Treg cells) was performed in 34 untreated patients with GCA or PMR, in comparison with 31 healthy control subjects and with the 27 treated patients who remained after the 7 others withdrew. RESULTS Compared with control subjects, patients with GCA and patients with PMR had a decreased frequency of Treg cells and Th1 cells, whereas the percentage of Th17 cells was significantly increased. Furthermore, an analysis of temporal artery biopsy specimens obtained from patients affected by GCA for whom biopsy results were positive demonstrated massive infiltration by Th17 and Th1 lymphocytes without any Treg cells. After glucocorticoid treatment, the percentages of circulating Th1 and Th17 cells decreased, whereas no change in the Treg cell frequency was observed. The frequency of CD161+CD4+ T cells, which are considered to be Th17 cell precursors, was similar in patients and control subjects. However, these cells highly infiltrated GCA temporal artery biopsy specimens, and their ability to produce interleukin-17 in vitro was significantly enhanced in patients with GCA and patients with PMR and was correlated with a decrease in the phosphorylated form of STAT-1. CONCLUSION This study is the first to demonstrate that the frequency of Treg cells is decreased in patients with GCA and patients with PMR, and that CD161+CD4+ T lymphocytes, differentiated into Th1 cells and Th17 cells, are involved in the pathogenesis of GCA and PMR.
Collapse
Affiliation(s)
- Maxime Samson
- Université de Bourgogne and CHU Dijon le Bocage, Dijon, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Cikes M, Tong L, Jasaityte R, Hamilton J, Sutherland G, D'hooge J, Yurdakul S, Oner F, Avci BK, Sahin S, Direskeneli H, Aytekin S, Fang F, Chan A, Zhang Q, Sanderson J, Kwong J, Yu C, Zaidi A, Raju H, Ghani S, Gati S, Cox A, Sheikh N, Sharma R, Sharma S, Kutty S, Kottam A, Padiyath A, Gao S, Drvol L, Lof J, Li L, Rangamani S, Danford D, Kuehne T, Rosner A, Avenarius D, Malm S, Iqbal A, Baltabaeva A, Schirmer H, Bijnens B, Myrmel T, Magalhaes A, Silva Marques J, Martins S, Carrilho Ferreira P, Jorge C, Silva D, Placido R, Goncalves S, Almeida A, Nunes Diogo A, Poulidakis E, Aggeli C, Sideris S, Dilaveris P, Gatzoulis K, Felekos I, Koutagiar I, Sfendouraki E, Roussakis G, Stefanadis C, Zhang Q, Sun J, Gao R, Feng Y, Liu X, Sheng W, Liu F, Yu C, Hallioglu O, Citirik D, Buyukakilli B, Ozeren M, Gurgul S, Tasdelen B, Rodriguez Lopez A, Rodriguez Lopez A, Garcia Cuenllas L, Garcia Cuenllas L, Medrano C, Medrano C, Granja S, Granja S, Marin C, Marin C, Maroto E, Maroto E, Alvarez T, Alvarez T, Ballesteros F, Ballesteros F, Camino M, Camino M, Centeno M, Centeno M, Alraies M, Aljaroudi W, Halley C, Rodriguez L, Grimm R, Thomas J, Jaber W, Knight D, Coghlan J, Muthurangu V, Grasso A, Toumpanakis C, Caplin M, Taylor A, Davar J, Mohlkert LA, Halvorsen C, Hallberg J, Sjoberg G, Norman M, Cameli M, Losito M, Lisi M, Natali B, Massoni A, Maccherini M, Chiavarelli M, Massetti M, Mondillo S, Sljivic A, Stojcevski B, Celic V, Pencic B, Majstorovic A, Cosic Z, Backovic S, Ilic-Djordjevic I, Muraru D, Gripari P, Esposito R, Tamborini G, Galderisi M, Ermacora D, Maffessanti F, Santoro C, Pepi M, Badano L, Bombardini T, Cini D, Picano E, Shahgaldi K, Gunyeli E, Sahlen A, Manouras A, Winter R, Banovic M, Vukcevic V, Ostojic M, Markovic Z, Mladenovic A, Trifunovic D, Stojkovic S, Bacic D, Dedovic D, Seferovic P, Huttin O, Coulibaly S, Mercy M, Schwartz J, Zinzius P, Sellal J, Popovic B, Marie P, Juilliere Y, Selton-Suty C, Gurzun MM, Ionescu A, Bahlay B, Jones G, Rimbas R, Enescu O, Mihaila S, Ciobanu A, Vinereanu D, Vlasseros I, Koumoulidis A, Tousoulis D, Veioglanis S, Avgeropoulou A, Katsi V, Stefanadis C, Kallikazaros I, Kiviniemi T, Ylitalo A, Airaksinen K, Lehtinen T, Saraste A, Pietila M, Karjalainen P, Trifunovic D, Ostojic M, Stankovic S, Vujisic-Tesic B, Petrovic M, Banovic M, Boricic M, Draganic G, Petrovic M, Stepanovic J, Kuznetsov V, Yaroslavskaya E, Pushkarev G, Krinochkin D, Zyrianov I, Dekleva M, Stevanovic A, Kleut M, Suzic Lazic J, Markovic Nikolic N, Akhunova S, Saifullina G, Sadykov A, Loudon M, D'arcy J, Arnold L, Reynolds R, Mabbet C, Prendergast B, Dahl J, Videbaek L, Poulsen M, Rudbaek T, Pellikka P, Rasmussen L, Moller J, Lowery C, Frenneaux M, Dawson D, Dwivedi G, Singh S, Rudd A, Mahadevan D, Srinivasan J, Jiminez D, Sahinarslan A, Vecchio F, Maccarthy P, Wendler O, Monaghan M, Harimura Y, Seo Y, Ishizu T, Noguchi Y, Aonuma K, Urdaniz MM, Palomares JFR, Rius JB, Surribas IB, Tura GT, Garcia-Moreno LG, Alujas TG, Masip AE, Mas PT, Dorado DG, Meimoun P, Germain A, Clerc J, Elmkies F, Zemir H, Luycx-Bore A, Nasr GM, Erraki A, Dulgheru R, Magne J, Capoulade R, Elhonsali Z, Pierard LA, Pibarot P, Lancellotti P, Wrideier S, Butz T, Schilling I, Gkiouras G, Sasko B, Van Bracht M, Prull M, Trappe HJ, Castillo Bernal F, Mesa Rubio M, Ruiz Ortiz M, Delgado Ortega M, Morenate Navio M, Baeza Garzon M, Del Pino ML, Toledano Delgado F, Mazuelos F, Suarez de Lezo Herreros de Tejada J, Prinz C, Schumann M, Burghardt A, Seggewiss H, Oldenburg O, Horstkotte D, Faber L, Bistola V, Banner N, Hedger M, Simon A, Rahman Haley S, Baltabaeva A, Adamyan K, Tumasyan LR, Chilingaryan A, Makavos G, Kouris N, Kostopoulos V, Stamatelatou M, Damaskos D, Kartsagoulis E, Olympios C, Sade L, Eroglu S, Bircan A, Pirat B, Sezgin A, Aydinalp A, Muderrisoglu H, Sargento L, Satendra M, Sousa C, Longo S, Lousada N, Dos Reis RP, Kuznetsov V, Krinochkin D, Gapon L, Vershinina A, Shurkevich N, Bessonova M, Yaroslavskaya E, Kolunin G, Sargento L, Satendra M, Sousa C, Lousada N, Dos Reis RP, Azevedo O, Lourenco M, Machado I, Guardado J, Medeiros R, Pereira A, Quelhas I, Lourenco A, Duman D, Sargin F, Kilicaslan B, Inan A, Ozgunes N, Goktas P, Ikonomidis I, Tzortzis S, Paraskevaidis I, Andreadou I, Katseli C, Katsimbri P, Papadakis I, Pavlidis G, Anastasiou-Nana M, Lekakis J, Charalampopoulos A, Howard L, Davies R, Gin-Sing W, Tzoulaki I, Grapsa I, Gibbs J, Dobson RA, Cuthbertson DJ, Burgess M, Lichodziejewska B, Kurnicka K, Goliszek S, Kostrubiec M, Dzikowska-Diduch O, Ciurzynski M, Krupa M, Grudzka K, Palczewski P, Pruszczyk P, Mansencal N, Marcadet D, Montalvan B, Dubourg O, Matveeva N, Nartsissova G, Chernjavskiy A, Eicher JC, Berthier S, Lorcerie B, Philip JL, Wolf JE, Wiesen P, Ledoux D, Massion P, Piret S, Canivet JL, Cusma-Piccione M, Zito C, Imbalzano E, Saitta A, Donato D, Madaffari A, Luzza G, Pipitone V, Tripodi R, Carerj S, Bombardini T, Gherardi S, Arpesella G, Maccherini M, Serra W, Del Bene R, Sicari R, Picano E, Al-Mallah M, Ananthasubramaniam K, Alam M, Chattahi J, Zweig B, Boedeker S, Song T, Khoo J, Davies J, Ang KL, Galinanes M, Chin D, Papamichael ND, Karassavidou D, Mpougialkli M, Antoniou S, Giannitsi S, Chachalos S, Gouva C, Naka K, Katopodis K, Michalis L, Tsang W, Cui V, Ionasec R, Takeuchi M, Houle H, Weinert L, Roberson D, Lang R, Altman M, Aussoleil A, Bergerot C, Sibellas F, Bonnefoy-Cudraz E, Derumeaux GA, Thibault H, Mohamed A, Omran A, Hussein M, Shahgaldi K, Gunyeli E, Sahlen A, Manouras A, Winter R, Squeri A, Binno S, Ferdenzi E, Reverberi C, Baldelli M, Barbieri A, Iaccarino D, Naldi M, Bosi S, Kalinowski M, Szulik M, Streb W, Stabryla J, Nowak J, Rybus-Kalinowska B, Kukulski T, Kalarus Z, Ouss A, Riezebos R, Nestaas E, Skranes J, Stoylen A, Brunvand L, Fugelseth D, Magalhaes A, Silva Marques J, Martins S, Carrilho Ferreira P, Placido R, Jorge C, Silva D, Goncalves S, Almeida A, Nunes Diogo A, Nagy A, Kovats T, Apor A, Nagy A, Vago H, Toth A, Toth M, Merkely B, Ranjbar S, Karvandi M, Hassantash S, Da Silva SG, Marin C, Rodriguez A, Marcos C, Rodriguez-Ogando A, Maroto E, Medrano C, Del Valle DI, Lopez-Fernandez T, Gemma D, Gomez-Rubin M, De Torres F, Feliu J, Canales M, Buno A, Ramirez E, Lopez-Sendon J, Magalhaes A, Silva Marques J, Martins S, Placido R, Silva D, Jorge C, Calisto C, Goncalves S, Almeida A, Nunes Diogo A, Jorge C, Cortez-Dias N, Goncalves S, Ribeiro S, Santos L, Silva D, Barreiros C, Bernardes A, Carpinteiro L, Sousa J, Kim SH, Choi W, Chidambaram S, Arunkumar R, Venkatesan S, Gnanavelu G, Dhandapani V, Ravi M, Karthikeyan G, Meenakshi K, Muthukumar D, Swaminathan N, Vitarelli A, Barilla F, Capotosto L, Truscelli G, Dettori O, Caranci F, D-Angeli I, De Maio M, De Cicco V, Bruno P, Doesch C, Sueselbeck T, Haghi D, Streitner F, Borggrefe M, Papavassiliu T, Laser K, Schaefer F, Fischer M, Habash S, Degener F, Moysich A, Haas N, Kececioglu D, Burchert W, Koerperich H, Dwivedi G, Al-Shehri H, Dekemp R, Ali I, Alghamdi A, Klein R, Scullion A, Beanlands R, Ruddy T, Chow B, Lipiec P, Szymczyk E, Michalski B, Wozniakowski B, Rotkiewicz A, Stefanczyk L, Szymczyk K, Kasprzak J, Angelov A, Yotov Y, Mircheva L, Kisheva A, Kunchev O, Ikonomidis I, Tsantes A, Triantafyllidi H, Tzortzis S, Dima K, Trivilou P, Papadopoulos C, Travlou A, Anastasiou-Nana M, Lekakis J, Bader R, Agoston-Coldea L, Lupu S, Mocan T, Loegstrup B, Hofsten D, Christophersen T, Moller J, Bjerre M, Flyvbjerg A, Botker H, Egstrup K, Park Y, Choi J, Yun K, Lee S, Han D, Kim J, Kim J, Kim J, Chun K. Poster Session Wednesday 5 December all day Display * Determinants of left ventricular performance. Eur Heart J Cardiovasc Imaging 2012. [DOI: 10.1093/ehjci/jes248] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Couturier M, Nicolas B, Audia S, Nguyen A, Leguy-Seguin V, Bonniaud B, Bonnotte B, Lorcerie B. Les dessous CHICS du méthotrexate. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
21
|
Antier N, Lorcerie B, Berthier S, Mambrini O, Bonnotte B, Leguy-Seguin V, Audia S. Une hypoglycémie d’étiologie inhabituelle. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
22
|
Cherin P, Kaminsky P, Serratrice C, Lidove O, Noel E, Masseau A, Lorcerie B, Maillot F, Jaussaud R, Lavigne C, Cabane J, Leporrier M. Parcours diagnostique de la maladie de Gaucher de type 1. Résultats d’une enquête multicentrique française portant sur 55 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
23
|
Cherin P, Serratrice C, Kaminsky P, Lidove O, Noel E, Masseau A, Lorcerie B, Maillot F, Jaussaud R, Lavigne C, Marie I, Cabane J. Troubles de la coagulation et de la fibrinolyse dans la maladie de Gaucher de type 1 : résultats d’une enquête multicentrique française portant sur 42 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Nicolas B, Audia S, Couturier M, Leguy-Seguin V, Bonnotte B, Lorcerie B. Un PTI atypique : quand les gènes s’en mêlent…. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
25
|
Samson M, Audia S, Leguy V, Berthier S, Janikashvili N, Martin L, Bonnotte B, Lorcerie B. Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange. Intern Med J 2012; 42:95-8. [PMID: 22276560 DOI: 10.1111/j.1445-5994.2011.02591.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Systemic lupus erythematosus (SLE) has been described as a cause of thrombotic microangiopathy, especially thrombotic thrombocytopenic purpura (TTP). Haemolytic-uraemic syndrome (HUS) is less frequent in SLE. We report a case of such an association during an episode of severe lupus nephritis in a young woman, who was successfully treated with steroids, cyclophosphamide and especially plasma exchange with plasma replacement. This report highlights the importance of recognising atypical HUS in SLE patients by looking for schistocytes in case of haemolytic anemia with a negative antiglobulin test, in order to begin plasma exchange.
Collapse
Affiliation(s)
- M Samson
- Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France.
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 2012; 307:948-55. [PMID: 22396517 DOI: 10.1001/jama.2012.250] [Citation(s) in RCA: 228] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
CONTEXT The only treatment available to restore normal cardiac output in patients with hereditary hemorrhagic telangiectasia (HHT) and cardiac failure is liver transplant. Anti-vascular endothelial growth factor treatments such as bevacizumab may be an effective treatment. OBJECTIVES To test the efficacy of bevacizumab in reducing high cardiac output in severe hepatic forms of HHT and to assess improvement in epistaxis duration and quality of life. DESIGN, SETTING, AND PATIENTS Single-center, phase 2 trial with national recruitment from the French HHT Network. Patients were 18 to 70 years old and had confirmed HHT, severe liver involvement, and a high cardiac index related to HHT. INTERVENTION Bevacizumab, 5 mg per kg, every 14 days for a total of 6 injections. The total duration of the treatment was 2.5 months; patients were followed up for 6 months after the beginning of the treatment. MAIN OUTCOME MEASURE Decrease in cardiac output at 3 months after the first injection, evaluated by echocardiography. RESULTS A total of 25 patients were included between March 2009 and November 2010. Of the 24 patients who had echocardiograms available for reread, there was a response in 20 of 24 patients with normalization of cardiac index (complete response [CR]) in 3 of 24, partial response (PR) in 17 of 24, and no response in 4 cases. Median cardiac index at beginning of the treatment was 5.05 L/min/m(2) (range, 4.1-6.2) and significantly decreased at 3 months after the beginning of the treatment with a median cardiac index of 4.2 L/min/m(2) (range, 2.9-5.2; P < .001). Median cardiac index at 6 months was significantly lower than before treatment (4.1 L/min/m(2); range, 3.0-5.1). Among 23 patients with available data at 6 months, we observed CR in 5 cases, PR in 15 cases, and no response in 3 cases. Mean duration of epistaxis, which was 221 minutes per month (range, 0-947) at inclusion, had significantly decreased at 3 months (134 minutes; range, 0-656) and 6 months (43 minutes; range, 0-310) (P = .008). Quality of life had significantly improved. The most severe adverse events were 2 cases of grade 3 systemic hypertension, which were successfully treated. CONCLUSION In this preliminary study of patients with HHT associated with severe hepatic vascular malformations and high cardiac output, administration of bevacizumab was associated with a decrease in cardiac output and reduced duration and number of episodes of epistaxis. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00843440.
Collapse
Affiliation(s)
- Sophie Dupuis-Girod
- Hospices Civils de Lyon, Hôpital Louis Pradel, Genetic Department and National Reference Center for Rendu-Osler Disease, Bron, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Gargani L, Moggi Pignone A, Agoston G, Moreo A, Pavellini A, Doveri M, Bazzichi L, Epis O, Bruschi E, Musca F, Badano L, Varga A, Bombardieri S, Sicari R, Picano E, Matucci Cerinic M, Gargani L, Agoston G, Capati E, Badano L, Moreo A, Caputo ML, Mondillo S, Varga A, Sicari R, Matucci Cerinic M, Picano E, Eicher J, Berthier S, Lorcerie B, Bonnotte B, Philip JL, Wolf JE, Codullo V, Cuomo G, Fusetti C, Borgogno E, Breda S, D'Alto M, Ghio S, Montecucco C, Valentini G, Caporali R, Codullo V, Cuomo G, Fusetti C, Breda S, Borgogno E, D'alto M, Ghio S, Caporali R, Montecucco C, Valentini G, Mical-Strak M, Sobieszczanska M, Laszki-Szczachor K, Morgiel E, Wiland P. S.5.1 Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in SSc: a multicentre study. Rheumatology (Oxford) 2012. [DOI: 10.1093/rheumatology/ker466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
28
|
Mausserey C, Sigonney V, Bonnotte B, Lorcerie B. Toxocarose mimant un syndrome de Shulamn. Rev Med Interne 2011. [DOI: 10.1016/j.revmed.2011.10.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
29
|
Manckoundia P, Lorenzini M, Disson-Dautriche A, Petit JM, Lorcerie B, Debost E, Menu D, Pfitzenmeyer P. Assessment of the use of hypolipidemic agents (HAs), mainly statins, in elderly subjects aged 80 years and more in Burgundy: analysis of 13,211 patients. Arch Gerontol Geriatr 2011; 55:101-5. [PMID: 21868109 DOI: 10.1016/j.archger.2011.06.025] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2011] [Revised: 06/20/2011] [Accepted: 06/21/2011] [Indexed: 11/25/2022]
Abstract
Only few studies have investigated the use of HA in elderly subjects and there are no data in very elderly subjects. We assessed the prescription of HA and analyzed the relationship between such prescriptions and frailty markers among persons aged 80 and more in an observational study. We recorded the prescriptions for 13,211 patients aged 80-109 years and affiliated to the "Mutualité-Sociale-Agricole (MSA)" of Burgundy over a 1-month period. The prescription of a HA among all included patients, and the existence of serious long-term disease(s) (LTD), polypharmacy or a prescription of cardiovascular drugs among patients receiving a HA were recorder. Among the 13,211 patients, 3412 aged 80-98 years were treated with an HA. The main HA were statins (70.4%), and fibrates were used in 27.3% of cases. Of these 3412 patients, 2250 had one or several LTD mainly coronaropathy, hypertension, diabetes mellitus or peripheral artery disease. The mean number of drugs per prescription was 6.37. Among subjects treated with HA, 40% also received antiplatelets, 35.6% β-blockers and 30% inhibitors of the renin-angiotensin system. For 99% of the patients, the prescription of HA was a renewal. Prescribers were mainly general practitioners (96.8%). Statins are the most widely prescribed HA even among very elderly subjects. However, after 80 years the prescription of HA, mainly statins, decreases with aging. This could be explained by polypathology, polypharmacy and the deterioration in metabolic functions which are markers of frailty. This study should encourage research into the use of statins in very elderly subjects.
Collapse
Affiliation(s)
- Patrick Manckoundia
- Service de Médecine Interne Gériatrie, Hôpital de Champmaillot, CHU, 2 rue Jules Violle, F-21079 Dijon Cedex, France.
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Biotti D, Osseby GV, Durand C, Lorcerie B, Couvreur S, Moreau T, Giroud M. Wernicke's encephalopathy due to hyperemesis gravidarum … and fetal stroke: What relationship? Clin Neurol Neurosurg 2011; 113:490-2. [DOI: 10.1016/j.clineuro.2011.01.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2009] [Revised: 11/22/2010] [Accepted: 01/24/2011] [Indexed: 10/18/2022]
|
31
|
Audia S, Falvo N, Leguy-Seguin V, Berthier S, Martin L, Bonnotte B, Lorcerie B. Scalp vein thrombosis mimicking giant cell arteritis relapse. Intern Med J 2011; 41:492-5. [DOI: 10.1111/j.1445-5994.2010.02396.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Samson M, Roch N, Audia S, Berthier S, Leguy V, Bonnotte B, Lorcerie B. [Tuberculous tenosynovitis]. Presse Med 2011; 40:877-81. [PMID: 21511428 DOI: 10.1016/j.lpm.2011.02.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2010] [Revised: 02/09/2011] [Accepted: 02/21/2011] [Indexed: 11/15/2022] Open
Affiliation(s)
- Maxime Samson
- CHU de Dijon, service de médecine interne et immunologie clinique, 21000 Dijon, France.
| | | | | | | | | | | | | |
Collapse
|
33
|
Vinit J, Bielefeld P, Muller G, Bonnotte B, Lorcerie B, Besancenot JF, Terriat B. Mesure systématique des index de pression systolique à la cheville pour le dépistage de l’artériopathie oblitérante des membres inférieurs dans les services de médecine interne : comparaison aux recommandations de la Haute Autorité de santé. Étude prospective descriptive chez 106 patients. Presse Med 2011; 40:e163-72. [DOI: 10.1016/j.lpm.2010.10.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2010] [Revised: 08/05/2010] [Accepted: 10/15/2010] [Indexed: 11/28/2022] Open
|
34
|
Eicher JC, Berthier S, Lorcerie B, Bonnotte B, Wolf JE. Prediction of exercise capacities and cardiac involvement in scleroderma patients using a novel Doppler echocardiographic parameter. Arch Cardiovasc Dis 2011. [DOI: 10.1016/j.acvd.2011.03.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Brunot S, Berthier S, Osseby GV, Ricolfi F, Lorcerie B, Moreau T, Giroud M. Abdominal aortic pathology revealed by cauda equina syndrome. Eur Neurol 2011; 65:198-200. [PMID: 21412006 DOI: 10.1159/000324326] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2009] [Accepted: 01/10/2011] [Indexed: 11/19/2022]
Affiliation(s)
- S Brunot
- Department of Neurology, University Hospital Center, Dijon, France.
| | | | | | | | | | | | | |
Collapse
|
36
|
Samson M, Audia S, Lakomy D, Trad M, Devilliers H, Vinit J, Manckoundia C, Maillefert JF, Martin L, Besancenot JF, Lorcerie B, Bonnotte B. Balance Th17/Treg au cours de la maladie de Horton et la Pseudopolyarthrite rhizomélique : une nouvelle cible thérapeutique ? Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.10.045] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
37
|
Lorcerie B. [The 62nd Congress of the French Society of Internal Medicine, Dijon, 8-10 December 2010]. Rev Med Interne 2010; 31 Suppl 3:S289. [PMID: 21067848 DOI: 10.1016/j.revmed.2010.09.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
38
|
Vinit J, Bielefeld P, Muller G, Pfitzenmeyer P, Bonniaud P, Lorcerie B, Besancenot JF. Heart involvement in Churg-Strauss syndrome: retrospective study in French Burgundy population in past 10 years. Eur J Intern Med 2010; 21:341-6. [PMID: 20603049 DOI: 10.1016/j.ejim.2010.05.004] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2009] [Revised: 04/29/2010] [Accepted: 05/10/2010] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Heart manifestations of Churg-Strauss syndrome (CSS) are varied. In the early stages of the disease, it is difficult to distinguish between lesions that are specific to CSS and those of other etiologies. The aim of our work was to compare the characteristics of patients with heart manifestations linked or not to Churg-Strauss syndrome. MATERIAL AND METHODS We recorded all clinical symptoms of patients with CSS hospitalized between 1998 and 2008 in Burgundy, France, and determined the possible relationships between heart symptoms and CSS. RESULTS From a cohort of 31 patients, we found 20 with heart lesions. When heart lesions were present, we noted fewer initial symptoms of digestive disorders (p<0.05), lower levels of lung infiltrates and fewer anti-MPO pANCA (p<0.05). Heart lesions were linked to CSS in 75% of cases. Their patients were thus younger than those in the other cardiac patients (p<0.05), were more likely to have clinical manifestations of heart involvement at diagnosis, were less likely to have lung infiltrates on the X-ray at diagnosis and during flare-ups and less likely to have lung abnormalities on X-rays during flare-ups (p<0.05) and higher level of leucocytes and eosinophils at diagnosis. CONCLUSION Heart lesions directly attributable to CSS are frequent, severe and probably underestimated. A specific physiopathology that is not mediated by ANCA seems to be involved in the genesis of CSS-related heart lesions.
Collapse
Affiliation(s)
- J Vinit
- Department of Internal Medicine and Systemic Diseases, General Hospital, University Hospital, 3 rue Faubourg Raines, Dijon Cedex, France.
| | | | | | | | | | | | | |
Collapse
|
39
|
Chérin P, Adoué D, Hachulla E, Jaussaud R, Kaminsky P, Lavigne C, Lidove O, Lorcerie B, Magy-Bertrand N, Maillot F, Marie I, Masseau A, Noel E, Serratrice C, Cabane J. Résultats de l’enquête sur les maladies rares coordonnée par le groupe médecine interne – maladies lysosomales. Rev Med Interne 2010; 31:515-6. [DOI: 10.1016/j.revmed.2010.01.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2009] [Revised: 12/30/2009] [Accepted: 01/12/2010] [Indexed: 11/30/2022]
|
40
|
Audia S, Leguy-Seguin V, Berthier S, Bonnotte B, Lorcerie B. Mononeuropathie au cours d’un purpura rhumatoïde. Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.03.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
41
|
Samson M, Audia S, Hamet M, Garnier F, Eicher JC, Pavon A, Prin S, Barbar S, Charles PE, Bonnotte B, Lorcerie B, Quenot JP. Expression cardiaque isolée, à l’âge de 76 ans, d’une amylose à transthyrétine mutée. Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.03.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
42
|
Audia S, Lakomy D, Guy J, Leguy-Seguin V, Berthier S, Aho S, Lorcerie B, Bonnotte B. Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients. Rev Med Interne 2010; 31:337-44. [DOI: 10.1016/j.revmed.2009.11.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2009] [Revised: 10/06/2009] [Accepted: 11/25/2009] [Indexed: 01/06/2023]
|
43
|
Vinit J, Muller G, Bielefeld P, Pfitzenmeyer P, Bonniaud P, Lorcerie B, Besancenot JF. Churg-Strauss syndrome: retrospective study in Burgundian population in France in past 10 years. Rheumatol Int 2009; 31:587-93. [PMID: 20039171 DOI: 10.1007/s00296-009-1275-y] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2009] [Accepted: 11/29/2009] [Indexed: 11/28/2022]
Abstract
Churg-Strauss Syndrome (SCS) is a systemic vasculitis associated with asthma and eosinophilia. The aim of our work is to describe this pathology in the Burgundian population in France. We counted from the hospitalisation data-processing summaries, the whole of the SCS hospitalised in Burgundy between 1998 and 2008. During the follow-up, the clinical and paraclinical characteristics of every patient were collected. The average prevalence is of 11.3 per million inhabitants and the incidence is of 1.2 new cases per million inhabitants per annum. There exists however, a great prevalence disparity and incidence amongst the various departments of the area. The patient's average follow-up is of 7.7 years. In 23% of the cases one finds a starting factor for vasculitis. The delay between the first signs and the diagnostic is an average of 61 months. The ANCA are positive in 26% of cases and of anti-myeloperoxidase specificity in 83% of cases (P < 0.001). The most profitable biopsies are essentially cutaneous and neuromuscular. At the diagnostic, two-third of the patients have had a treatment adapted according to the current recommendations based on the Five Factor Score. The remission rate within a 1-year period is of 77%. The remission is strongly correlated to the therapeutic protocol associating corticoids and cyclophosphamide (P < 0.05). In conclusion, the prevalence of SCS in our area is similar to that observed in other European regions. However, this vasculitis remains a difficult and often a tardive diagnostic pathology.
Collapse
Affiliation(s)
- Julien Vinit
- Department of Internal Medicine and Systemic Diseases, General Hospital, University Hospital, Dijon Cedex, France.
| | | | | | | | | | | | | |
Collapse
|
44
|
Leguy-Seguin V, Audia S, Devilliers H, Samson M, Maurier F, Jaussaud R, Gil H, Dupond J, Dupond A, Bonnotte B, Lorcerie B. Fasciite avec éosinophilie ou maladie de Shulman : apport de l’IRM, du Pet-scan et des nouvelles thérapeutiques dans le diagnostic et le traitement de cette affection. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.10.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
45
|
Audia S, Falvo N, Leguy-Seguin V, Berthier S, Bonnotte B, Lorcerie B. Céphalée au cours d’une maladie de Horton : un piège diagnostique. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.10.338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
46
|
Audia S, Combret S, Leguy-Seguin V, Sgro C, Bonnotte B, Lorcerie B. Un médicament délirant…. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.10.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
47
|
Riviere S, Pelenc D, Dupuis-Girod S, Lorcerie B, Kaminsky P, Le Quellec A, Plauchu H. Maladie de Rendu Osler : nouveau facteur de risque de thrombose ? Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.03.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
48
|
Audia S, Lakomy D, Vinit J, Leguy V, Olsson NO, Besancenot JF, Lorcerie B, Bonnotte B. Anticorps anti-Sm dosés par immunofluorimétrie en flux au cours du lupus érythémateux disséminé. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.03.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
49
|
Audia S, Leguy V, Berthier S, Bonnotte B, Lorcerie B. Purpura thrombopénique immunologique : étude rétrospective descriptive de 40 patients et réponse aux traitements. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.03.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
50
|
Abstract
The occurrence of a retroperitoneal fibrosis (RPF) after an aorto-bifemoral bypass is unusual. A case of RPF as a complication of an infection of the graft prosthesis is reported. Computed tomography and magnetic resonance imaging prove useful in diagnosing graft infection: they may reveal periprosthetic gas or perigraft fluid persisting for several months after surgery. However, they may fail when they are performed too early, and repeat performance is suggested.
Collapse
Affiliation(s)
- C Cuny
- Service de Médecine Interne et Immunologie Clinique, Hôpital du Bocage, Dijon, France
| | | | | | | |
Collapse
|